Ganga Pharmaceuticals Limited has intimated BSE Limited about an upcoming Board of Directors meeting scheduled for November 2, 2026. The primary agenda of the meeting is to consider and approve the un-audited financial results of the company for the half year ended September 30, 2026.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
In accordance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's securities has been closed since October 1, 2026 for all designated persons of the company. The trading window will remain closed until 48 hours after the financial results are declared to the stock exchange.